At <a href='https://www.linkedin.com/feed/hashtag/?keywords=AHA24&highlightedUpdate…; target='_blank'>#AHA24</a>, attendees explored the benefits of Hybrid AF™ Therapy and learned new data from the DEEP Trial, highlighting improved quality of life for patients who underwent hybrid ablation and Left Atrial Appendage Exclusion (LAAE) with an AtriClip® device.
Thank you to all the physicians who connected with us, your collaboration is vital in driving innovation in Afib treatment!